Overview of motor neuron disease: Classification and nomenclature

Clinical Neuroscience

Volumn 3, Issue 6, 1995, Pages 323-326

  Bradley, Walter G ^a,b,c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Neuromuscular Clinical and Research Center ^*  (United States)

^c American Neurological Association   (United States)

Author keywords

diagnostic criteria; familial ALS; phenotypic subtypes; psychological aspects; upper and lower motor neuron

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; GENE MUTATION; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SPINAL MUSCULAR ATROPHY;

AMYOTROPHIC LATERAL SCLEROSIS; HUMANS; MOTOR NEURON DISEASE; TERMINOLOGY;

EID: 0029435250     PISSN: 10656766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. Bradley WG (1987): Amyotrophic lateral sclerosis and Duchenne muscular dystrophy: The diseases and the doctorpatient relationship. In Charash LI, Lovelace RE, et al (eds): Realities in Coping With Progressive Neuromuscular Diseases. Charles Press, pp 3-20.
2. Bradley WG (1994): Amyotrophic lateral sclerosis: The diagnostic process.' In Mitsumoto H, Morris FH (eds): Amyotrophic Lateral Sclerosis: A Comprehensive Guide to Management. New York: Demos, pp 21-28.
3. Brooks BR (1996): Emerging directions in ALS therapeutics: Palliative therapies at the advent of the twenty-first century. Clinical Neuroscience 3:386-392.
4. El Escortai Workshop (1994): World Federation of Neurology Criteria for the Diagnosis of Amyotrophic Lateral Sclerosis. J Neurol Sei 124(suppl):96-107.
5. Juneja T, Dave S, Siddique T (1995): Survival predication in familial amyotrophic lateral sclerosis: Specific mutations in Cu,Zn Superoxide dismutase are associated with disease severity and progression. Am JHumGenet 57(suppl).
6. Juneja T, Dave S, Pericak-Vance MA, Siddique T (1996) Prognosis in familial ALS: Progression and survival in pa-tients with glulOOgly and ala4 val mutations in Cu,Zn Superoxide dismutase. Neurolgoy (in press).
7. Mulder DW, Kurland LT, Offord KP, Beard CM (1986): Familial adult motor neuron disease: Amyotrophic lateral sclerosis. Neurology 36:511-517.
8. Siddique T, Hentati A (1996): Familial Amyotrophic Lateral Sclerosis. Clinical Neuroscience 3:338-347.
9. Tandan R, Bradley WG (1985a): Amyotrophic lateral sclerosis. Part I. Clinical features, pathology and ethical issues in management. Ann Neurol 18:271-280.
10. Tandan R, Bradley WG (1985b): Amyotrophic lateral sclerosis. Part II. Etiopathogenesis. Ann Neurol 18:419-431.
11. Tsai CP, Ho HH, Yen DC, et al (1993): Possible motor neuron disease. Eur Neurol 33:387-389.
12. Tucker T, Layzer RB, Miller RG, Chad D (1991): Subacute reversible motor neuron disease. Neurology 41:1541-1544.